Just – Evotec Biologics Receives Grant from Gates Foundation for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access

Just – Evotec Biologics has received a new Gates Foundation grant to advance global access to biotherapeutics by improving the developability and affordability of monoclonal antibodies. The funding will support ten new projects leveraging its J.MD™ computational molecular design technologies to reduce cost of goods and accelerate development of therapies targeting priority global health diseases.